Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP571454.RAVlA6UAXcYvolGXc3z3dXhwi0qS8YspA82Dhm8rNpY3A130_assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571454.RAVlA6UAXcYvolGXc3z3dXhwi0qS8YspA82Dhm8rNpY3A130_provenance.
• NP718855.RAdLVin_u0KOXfXWdFxc3-GOf5Y4K90nqWya9uSxW5hHE130_assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718855.RAdLVin_u0KOXfXWdFxc3-GOf5Y4K90nqWya9uSxW5hHE130_provenance.
• assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP718861.RAqhHAxfXdCp7BMnek8Q-RviSDTFu1Kn3BTbJDHOSjWuw130_assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718861.RAqhHAxfXdCp7BMnek8Q-RviSDTFu1Kn3BTbJDHOSjWuw130_provenance.
• NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_provenance.
• NP1152475.RAC1VgjOwqjZeKUzHLoG47c7turRGwyBfTxrDEgtvrzA4130_assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1152475.RAC1VgjOwqjZeKUzHLoG47c7turRGwyBfTxrDEgtvrzA4130_provenance.
• NP1152477.RAcSOM2LA-0c-GPVcd_ItdH0XJH0vXGxiU91n2cZVD3Jw130_assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1152477.RAcSOM2LA-0c-GPVcd_ItdH0XJH0vXGxiU91n2cZVD3Jw130_provenance.
• NP388998.RAhYm5bqXUQCHShfjQz_e-LHDeFicQonwtQnAcycIKXm0130_assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP388998.RAhYm5bqXUQCHShfjQz_e-LHDeFicQonwtQnAcycIKXm0130_provenance.
• NP389038.RA5seQerZ9ftFh4G46T5SHeXv7k45MLTI49vFglu4yFeo130_assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389038.RA5seQerZ9ftFh4G46T5SHeXv7k45MLTI49vFglu4yFeo130_provenance.
• NP571435.RALhbviLsmfkvIcs74H639A7zqCDNxloap8fb1Gj3HpcU130_assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571435.RALhbviLsmfkvIcs74H639A7zqCDNxloap8fb1Gj3HpcU130_provenance.
• NP1152470.RA7CJPDiDm8X_sRRFgV945sxnELNOPz9ehvnLHrx6wU1o130_assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1152470.RA7CJPDiDm8X_sRRFgV945sxnELNOPz9ehvnLHrx6wU1o130_provenance.
• NP1152473.RA9E0TK13Q5zyW2jt_5WJ2Hhkl5OvLxHNNvJwlLXDFkaU130_assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1152473.RA9E0TK13Q5zyW2jt_5WJ2Hhkl5OvLxHNNvJwlLXDFkaU130_provenance.
• NP1152474.RAxbQG_Iad4Dw09ojWIro9GdRqdUjv4obtNbi_5fZuWGE130_assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1152474.RAxbQG_Iad4Dw09ojWIro9GdRqdUjv4obtNbi_5fZuWGE130_provenance.